Login / Signup

Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study.

Elena PezzoloMariaTeresa RossiFrancesca CaroppoTommaso BianchelliAnna Belloni FortinaAlfredo GiacchettiPiergiacomo Calzavara PintonLuigi Naldi
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
  • atopic dermatitis
  • drug induced
  • high intensity
  • early onset
  • free survival
  • adverse drug
  • emergency department